rs565513365
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PVS1_ModeratePM2PP5
The ENST00000196061.5(PLOD1):c.1651-2A>C variant causes a splice acceptor change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000689 in 1,451,150 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
ENST00000196061.5 splice_acceptor
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PLOD1 | NM_000302.4 | c.1651-2A>C | splice_acceptor_variant | ENST00000196061.5 | NP_000293.2 | |||
PLOD1 | NM_001316320.2 | c.1792-2A>C | splice_acceptor_variant | NP_001303249.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PLOD1 | ENST00000196061.5 | c.1651-2A>C | splice_acceptor_variant | 1 | NM_000302.4 | ENSP00000196061 | P1 | |||
PLOD1 | ENST00000491536.5 | n.279-2A>C | splice_acceptor_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.89e-7 AC: 1AN: 1451150Hom.: 0 Cov.: 29 AF XY: 0.00 AC XY: 0AN XY: 722712
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Ehlers-Danlos syndrome, kyphoscoliotic type 1 Pathogenic:1Uncertain:1
Pathogenic, criteria provided, single submitter | clinical testing | Genomic Research Center, Shahid Beheshti University of Medical Sciences | Mar 05, 2018 | - - |
Uncertain significance, criteria provided, single submitter | curation | Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard | May 02, 2023 | The homozygous c.1651-2A>C variant in PLOD1 was identified by our study in one individual with Ehlers-Danlos syndrome kyphoscoliotic type 1. The c.1651-2A>C variant in PLOD1 has not been previously reported in individuals with Ehlers-Danlos syndrome kyphoscoliotic type 1. This variant is absent in population databases. This variant has also been reported in ClinVar (Variation ID: 548602) and has been interpreted as pathogenic by the Genomic Research Center, Shahid Beheshti University of Medical Sciences. A different nucleotide change that also results in a splice acceptor variant at the same site, c.1651-2A>G (ClinVar Variation ID: 265507), has been previously reported pathogenic, and the variant being assessed here, c.1651-2A>C, is predicted by SpliceAI to have a similar effect on splicing. This variant is located in the 3' splice region. Computational tools predict a splicing impact, though this information is not predictive enough to determine pathogenicity. There is an in-frame cryptic splice site 39 bases from the intron-exon boundary, providing evidence that this variant may add 13 amino acids instead of causing loss of function. However, this information is not predictive enough to determine pathogenicity. Loss of function of the PLOD1 gene is an established disease mechanism in autosomal recessive Ehlers-Danlos syndrome kyphoscoliotic type 1. In summary, while there is some suspicion for a pathogenic role, the clinical significance of this variant is uncertain. ACMG/AMP Criteria applied: PVS1_Moderate, PS1_Supporting, PM2_Supporting, PM3_Supporting (Richards 2015). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at